New Investigation Casts Doubt on Landmark Ticagrelor Trial
New questions about the landmark trial that launched the antiplatelet drug ticagrelor worldwide are being raised after an investigation uncovered more information about how the PLATO study was conducted. Peter Doshi, PhD, senior editor at The BMJ, obtained …